Added to YB: 2024-05-14
Pitch date: 2024-03-31
HBIO [bullish]
Harvard Bioscience, Inc.
-82.48%
current return
Author Info
Riverwater Partners is a Milwaukee-based investment advisory firm dedicated to responsible investing. Visit the website.
Company Info
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.
Market Cap
$29.4M
Pitch Price
$4.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
8.98
P/E
-0.54
EV/Sales
0.75
Sector
Life Sciences Tools and Services
Category
turnaround
Riverwater Micro Opportunities Strategy Portfolio Holding: Harvard Bioscience, Inc.
HBIO: Positioned for resurgence in H2 2024 driven by anticipated pharma & biotech spending uptick. Increased position after earnings call & CEO chat. Set to benefit from expected growth trajectory.
Read full article (1 min)